PRDX1 promotes clear cell renal cell carcinoma progression by modulating EGFR-dependent AKT pathway activation

BackgroundRenal cell carcinoma (RCC) is a highly heterogeneous malignant tumor, characterized by a globally increasing incidence and mortality rate. Although surgical resection serves as the standard treatment for localized RCC, recurrence and metastasis remain major clinical challenges. Based on pa...

Description complète

Détails bibliographiques

Auteurs principaux:	Zhi Liang, Xiaochun Lin, Shen Zeng, Lili Wu, Yujun Dong, Chen Zhang, Mei Li, Fudi Zhu, Lu Chen, Suiqin Ni
Format:	Artigo
Langue:	Inglês
Publié:	Frontiers Media S.A. 2026-04-01
Collection:	Frontiers in Pharmacology
Sujets:	clear cell renal cell carcinoma clinical prognosis EGFR signaling pathway peroxiredoxin 1 survival rate
Accès en ligne:	https://www.frontiersin.org/articles/10.3389/fphar.2026.1741879/full
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!